Efficacy and safety comparison of hetrombopag and eltrombopag in children with cancer therapy-induced thrombocytopenia: a single-center retrospective study.

Hengqu (hetrombopag) - Jiangsu Hengrui Pharma

Promacta (eltrombopag) - Novartis

http://www.ncbi.nlm.nih.gov/pubmed/42694412

An-An Zhang; Dan He; Hao-Nan Li; Jia-Xin Zhang; Li-Ting Yu; Min Zhang; Yi-Jin Gao; Zhi-Ling Li; Zhuo Wang

Sep 5, 2026